|
Volumn 36, Issue 2, 2000, Pages 487-492
|
High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
ANGIOTENSIN;
ATRIAL NATRIURETIC FACTOR;
AZATHIOPRINE;
CAPTOPRIL;
CYCLOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
PREDNISONE;
SODIUM;
VASOPRESSIN;
ADULT;
ALDOSTERONE BLOOD LEVEL;
ANGIOTENSIN BLOOD LEVEL;
ANTIHYPERTENSIVE THERAPY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG MEGADOSE;
EXTRACELLULAR FLUID;
GRAFT REJECTION;
HEART FAILURE;
HEART TRANSPLANTATION;
HUMAN;
HYPERTENSION;
HYPERVOLEMIA;
IMMUNOSUPPRESSIVE TREATMENT;
MALE;
PATHOPHYSIOLOGY;
PLASMA VOLUME;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SALT INTAKE;
VASOPRESSIN BLOOD LEVEL;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
CAPTOPRIL;
CROSS-OVER STUDIES;
HEART TRANSPLANTATION;
HEMODYNAMIC PROCESSES;
HUMANS;
KIDNEY;
MALE;
MIDDLE AGED;
PLASMA VOLUME;
RENIN-ANGIOTENSIN SYSTEM;
VENTRICULAR FUNCTION, LEFT;
|
EID: 0033903429
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(00)00753-1 Document Type: Article |
Times cited : (11)
|
References (30)
|